PBM logo

Psyence Biomedical (PBM)

Profile

Full Name

Psyence Biomedical Ltd.

Ticker Symbol

PBM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

December 10, 2021

Indexes

Not included

Website

http://www.psyencebiomed.com

Employees

10

Key Details

Price

$0.46(-5.91%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$586.50(-3008.39% YoY)

PE ratio

0.01

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.46
PBM price is $0.46

30-Day Relative Volume

0.48
PBM 30-day relative volume is 0.48

Price Performance

Price Most recent change

-5.91%
PBM price was down -5.91% on Apr 16, 2025

Price YTD change

-77.97%
PBM price is down -77.97% since January 1st

Price 1-year change

-99.11%
PBM price is down -99.11% year-on-year

Price 3-year change

-99.94%
PBM price is down -99.94% over the past 3 years

Price Range

Price All-time high

$1091.25
PBM price is currently -99.96% below its historical high of $1091.25

Price 3-year low

$0.06
PBM price is currently +715.44% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.82M
PBM market capitalization is $1.82 million

Market cap 3-year change

-
PBM market capitalization 3-year change is unknown

Market cap All-time high

$185.40M
PBM market capitalization is currently -99.02% below its historical high of $185.40 million

Market cap sector rank

6.41%
PBM market capitalization is higher than 6.41% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2088.85%
PBM shares outstanding is up +2088.85% year-on-year

Shares Outstanding 3-Year Change

-
PBM shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.38
PBM beta is 1.38

200-day SMA

$10.64
PBM price is currently -95.63% below its 200-day simple moving average

50-day SMA

$0.89
PBM price is currently -47.65% below its 50-day simple moving average

RSI

30.27
PBM 14-day relative strength index is 30.27

Volume

0.48
PBM 30-day relative volume is 0.48

ATR

$0.08
PBM average true range is $0.08

10-day Historical Volatility

128.19%
PBM 10-day historical volatility is 128.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PBM annual revenue value is unknown

Revenue Analysts estimate

-
PBM annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PBM annual revenue 1-year change is unknown

Revenue Sector rank

-
PBM annual revenue is unknown

EPS

EPS

-$586.50
PBM annual earnings per share is -$586.50

EPS Analysts estimate

-
PBM annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-3008.39%
PBM annual earnings per share is down -3008.39% year-on-year

EPS Sector rank

0.58%
PBM annual earnings per share is higher than 0.58% of companies in Healthcare sector

Profit

Gross profit

-
PBM annual gross profit value is unknown

Gross margin

-
PBM annual gross profit margin value is unknown

Operating profit

-$44.23M
PBM annual operating income is -$44.23 million

Operating margin

-
PBM annual operating profit margin value is unknown

Net income

-$51.16M
PBM annual net profit is -$51.16 million

Net margin

-
PBM annual net profit margin value is unknown

Expenses

Total expenses

$44.23M
PBM annual total expenses is $44.23 million

Operating expenses

$44.23M
PBM annual total operating expenses is $44.23 million

Cost of goods sold

-
PBM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$1.80M
PBM annual SGA is $1.80 million

Depreciation and amortization

$200.00
PBM annual depreciation & amortization is $200.00

Interest expense

$52.90K
PBM annual interest expense is $52.90 thousand

Income tax

-
PBM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$51.11M
PBM annual earnings before interest & taxes is -$51.11 million

EBITDA

-$51.11M
PBM annual EBITDA is -$51.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.13M
PBM annual total assets is $1.13 million

Non current assets

$5500.00
PBM annual long term assets is $5500.00

Current assets

$1.13M
PBM annual total current assets is $1.13 million

Cash and cash equivalents

$733.20K
PBM annual cash & cash equivalents is $733.20 thousand

Accounts receivable

-
PBM annual accounts receivable value is unknown

Inventory

-
PBM annual inventory value is unknown

Liabilities

Total liabilities

$12.10M
PBM annual total liabilities is $12.10 million

Long term liabilities

$0.00
PBM annual total long term liabilities is $0.00

Current liabilities

$12.10M
PBM annual total current liabilities is $12.10 million

Accounts payable

$562.40K
PBM annual accounts payable is $562.40 thousand

Debt

Total debt

$10.45M
PBM annual total debt is $10.45 million

Total debt 1-year change

+100%
PBM annual total debt is up +100% year-on-year

Long term debt

-
PBM annual long term debt value is unknown

Short term debt

$10.45M
PBM annual short term debt is $10.45 million

Equity & Capital

Shareholders equity

-$10.97M
PBM annual stockholders equity is -$10.97 million

Book value

-$10.97M
PBM annual book value is -$10.97 million

Retained earnings

-$57.46M
PBM annual retained earnings is -$57.46 million

Working capital

-$10.98M
PBM annual working capital is -$10.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.95M
PBM annual cash flow from operations is -$2.95 million

Cash from operations 1-year change

-85%
PBM annual cash flow from operations is down -85% year-on-year

Cash from investing

-$5700.00
PBM annual cash flow from investing activities is -$5700.00

Cash from investing 1-year change

-100%
PBM annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$2.35M
PBM annual cash flow from financing activities is $2.35 million

Cash from financing 1-year change

+100.36%
PBM annual cash flow from financing activities is up +100.36% year-on-year

CAPEX

CAPEX

-
PBM annual capital expenditures value is unknown

CAPEX 1-year change

-
PBM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$2.95M
PBM annual free cash flow is -$2.95 million

Free cash flow 1-year change

-85.36%
PBM annual free cash flow is down -85.36% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PBM annual gross profit margin value is unknown

Operating margin

-
PBM annual operating profit margin value is unknown

Net margin

-
PBM annual net profit margin value is unknown

ROA & ROE

ROA

-4518.55%
PBM annual return on assets is -4518.55%

ROE

466.25%
PBM annual return on equity is 466.25%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

0.01
PBM price to earnings ratio is 0.01

PE ratio Sector rank

0.49%
PBM price to earnings ratio is higher than 0.49% of companies in Healthcare sector

PB Ratio

PB ratio

-1.45
PBM price to book ratio is -1.45

PB ratio Sector rank

7.24%
PBM price to book ratio is higher than 7.24% of companies in Healthcare sector

PS Ratio

PS ratio

-
PBM price to sales ratio value is unknown

PS ratio Sector rank

-
PBM price to sales ratio is unknown

Enterprise value

Enterprise value

$2.38M
PBM enterprise value is $2.38 million

Enterprise value Sector rank

15.8%
PBM enterprise value is higher than 15.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.31
PBM EV/EBITDA is 16.31

EV/EBITDA Sector rank

89.03%
PBM EV/EBITDA is higher than 89.03% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.09
PBM annual current ratio is 0.09

Quick ratio

-
PBM annual quick ratio value is unknown

Leverage

Debt to equity

-0.95
PBM annual debt to equity ratio is -0.95

Interest coverage ratio

-966.09
PBM annual interest coverage ratio is -966.09

Risk & Stability

Piotroski F-Score

-
PBM piotroski f-score value is unknown

Altman Z-Score

-
PBM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

ENTO logo
Entero Therapeutics (ENTO)
CERO logo
CERo Therapeutics Holdings (CERO)
ELAB logo
Elevai Labs (ELAB)
ZVSA logo
ZyVersa Therapeutics (ZVSA)
NDRA logo
ENDRA Life Sciences (NDRA)
FOXO logo
FOXO Technologies (FOXO)
PTIX logo
Protagenic Therapeutics (PTIX)
Scinai Immunotherapeutics (SCNI)
AKAN logo
Akanda (AKAN)
  • What is the ticker symbol for Psyence Biomedical?
  • Does Psyence Biomedical pay dividends?
  • What sector is Psyence Biomedical in?
  • What industry is Psyence Biomedical in?
  • What country is Psyence Biomedical based in?
  • When did Psyence Biomedical go public?
  • Is Psyence Biomedical in the S&P 500?
  • Is Psyence Biomedical in the NASDAQ 100?
  • Is Psyence Biomedical in the Dow Jones?
  • When does Psyence Biomedical report earnings?

What is the ticker symbol for Psyence Biomedical?

The ticker symbol for Psyence Biomedical is NASDAQ:PBM

Does Psyence Biomedical pay dividends?

No, Psyence Biomedical does not pay dividends

What sector is Psyence Biomedical in?

Psyence Biomedical is in the Healthcare sector

What industry is Psyence Biomedical in?

Psyence Biomedical is in the Biotechnology industry

What country is Psyence Biomedical based in?

Psyence Biomedical is headquartered in Canada

When did Psyence Biomedical go public?

Psyence Biomedical's initial public offering (IPO) was on December 10, 2021

Is Psyence Biomedical in the S&P 500?

No, Psyence Biomedical is not included in the S&P 500 index

Is Psyence Biomedical in the NASDAQ 100?

No, Psyence Biomedical is not included in the NASDAQ 100 index

Is Psyence Biomedical in the Dow Jones?

No, Psyence Biomedical is not included in the Dow Jones index

When does Psyence Biomedical report earnings?

The date for Psyence Biomedical's next earnings report has not been announced yet
On this page